Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × Radiotherapy, Conformal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Glioblastoma 4 Gliosarcoma 3 Brain Neoplasms 3 Stomach Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Central Nervous System Neoplasms 2 Breast Neoplasms 2 Adenocarcinoma of Lung 2 Vulvar Neoplasms 1 Vomiting 1 Urinary Bladder Neoplasms 1 Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Salivary Gland Neoplasms 1 Radiodermatitis 1 Pleural Effusion, Malignant 1 Ovarian Neoplasms 1 Osteosarcoma 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Nausea 1

Interventions

Cisplatin 80 Fluorouracil 66 Paclitaxel 62 Radiotherapy 56 Oxaliplatin 51 Irinotecan 35 Docetaxel 34 Leucovorin 32 Carboplatin 30 Capecitabine 26 Radiation 25 Surgical Procedures, Operative 20 pembrolizumab 17 Drug Therapy 15 Bevacizumab 15 Cetuximab 14 Nivolumab 12 tislelizumab 11 Chemoradiotherapy 11 Albumin-Bound Paclitaxel 10 camrelizumab 9 S 1 (combination) 9 Neoadjuvant Therapy 9 Esophagectomy 9 nimotuzumab 8 durvalumab 8 Trastuzumab 8 Radiotherapy, Intensity-Modulated 7 Gefitinib 7 nedaplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00815308 2011-02-08

EXCEL

Shandong Cancer Hospital and Institute

Phase 2 Completed

55 enrolled 9 charts

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡